# PEG-3350, SODIUM SULFATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE, SODIUM ASCORBATE AND ASCORBIC ACID
> **ANDA090145** · Abbreviated New Drug Application (Generic) · Sponsor: NOVEL LABS INC · Approved 2012-01-25
## Drug
- **FDA Application Number:** ANDA090145
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** PEG-3350, SODIUM SULFATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE, SODIUM ASCORBATE AND ASCORBIC ACID
- **Generic name:** PEG-3350, SODIUM SULFATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE, SODIUM ASCORBATE AND ASCORBIC ACID
- **Active ingredients:** ASCORBIC ACID; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM ASCORBATE; SODIUM CHLORIDE; SODIUM SULFATE
- **Dosage form:** FOR SOLUTION
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** NOVEL LABS INC
- **Manufacturer:** Teva Pharmaceuticals USA, Inc.
- **First approval:** 2012-01-25
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=090145)
---
*AI Analytics · CC0 1.0*